Deena M. Maurer

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Christopher R. Cabanski, Vanessa M. Hubbard-Lucey, E. Wherry, 2022, Nature Medicine.

Melanoma vaccines: clinical status and immune endpoints

L. Butterfield, L. Vujanovic, Deena M. Maurer, 2019, Melanoma research.

Interleukin 32 expression in human melanoma

T. Graeber, A. Ribas, L. Butterfield, 2019, Journal of Translational Medicine.

Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma

Amy Rose, J. Kirkwood, H. Tawbi, 2021, Journal for ImmunoTherapy of Cancer.

Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma

Patricia M. Santos, J. Kirkwood, H. Tawbi, 2019, Journal of Immunotherapy for Cancer.

Dysregulated NF-κB–Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma

Patricia M. Santos, J. Kirkwood, L. Butterfield, 2020, Cancer Immunology Research.

Interleukin 32 expression in human melanoma

T. Graeber, A. Ribas, L. Butterfield, 2019, Journal of translational medicine.